APA

Dawson L. M., Smith K. N., Werdyani S., Ndikumana R., Penney C., Wiede L. L., Smith K. L., Pater J. A., MacMillan A., Green J., Drover S., Young T. & O'Rielly D. D. (20210326). A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect. : Molecular genetics & genomic medicine.

Chicago

Dawson Lesa M, Smith Kerri N, Werdyani Salem, Ndikumana Robyn, Penney Cindy, Wiede Louisa L, Smith Kendra L, Pater Justin A, MacMillan Andrée, Green Jane, Drover Sheila, Young Terry-Lynn and O'Rielly Darren D. 20210326. A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect. : Molecular genetics & genomic medicine.

Harvard

Dawson L. M., Smith K. N., Werdyani S., Ndikumana R., Penney C., Wiede L. L., Smith K. L., Pater J. A., MacMillan A., Green J., Drover S., Young T. and O'Rielly D. D. (20210326). A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect. : Molecular genetics & genomic medicine.

MLA

Dawson Lesa M, Smith Kerri N, Werdyani Salem, Ndikumana Robyn, Penney Cindy, Wiede Louisa L, Smith Kendra L, Pater Justin A, MacMillan Andrée, Green Jane, Drover Sheila, Young Terry-Lynn and O'Rielly Darren D. A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect. : Molecular genetics & genomic medicine. 20210326.